These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37356950)

  • 1. [Platelet Transfusion Strategies for MASPAT-Matched Platelet Transfusion Failed Patient with Allogeneic Hematopoietic Stem Cell Transplantation].
    Yang L; Ma CY; Fu LH; Tai SF; Ma MZ; Zhong XL; Fan B; Wang XX; Wang DQ; Yu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):850-854. PubMed ID: 37356950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].
    Zhang RL; Zheng XH; Zhou LK; Zhang Y; Chen SL; Yang DL; Jiang EL; Wei JL; Huang Y; Ma QL; Zhai WH; Feng SZ; Han MZ; He Y
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):190-195. PubMed ID: 29562462
    [No Abstract]   [Full Text] [Related]  

  • 3. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
    Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.
    Zhang R; He Y; Yang D; Jiang E; Ma Q; Pang A; Zhai W; Wei J; Feng S; Han M
    J Clin Lab Anal; 2020 Jul; 34(7):e23261. PubMed ID: 32112480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia].
    Uchiyama Y; Hoshino T; Mihara M; Mitsui T; Koiso H; Takizawa M; Yokohama A; Saitoh T; Uchiumi H; Handa H; Tsukamoto N; Murakami H; Nojima Y
    Rinsho Ketsueki; 2013 Feb; 54(2):214-8. PubMed ID: 23470830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
    Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the role of HLA antibodies in hematopoietic stem cell transplantation.
    Brand A; Doxiadis IN; Roelen DL
    Tissue Antigens; 2013 Jan; 81(1):1-11. PubMed ID: 23216286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Solves P; Sanz J; Freiria C; Santiago M; Villalba A; Gómez I; Montesinos P; Montoro J; Piñana JL; Lorenzo JI; Puig N; Sanz GF; Sanz MÁ; Carpio N
    Ann Hematol; 2018 Jan; 97(1):161-167. PubMed ID: 29150812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection.
    Krummey SM; Gareau AJ
    Front Immunol; 2022; 13():916200. PubMed ID: 35990679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relevance of antibodies in hematopoietic stem cell transplantation: Antibodies anti-HLA, anti-platelets, anti-granulocytes, anti-erythrocytes and anti-MICA. Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Delbos F; Blouin L; Bruno B; Crocchiolo R; Desoutter J; Detrait M; Nguyen-Lejarre KT; Giannoli C; Lemarié C; Renac V; Yakoub-Agha I; Dubois V
    Bull Cancer; 2020 Dec; 107(12S):S159-S169. PubMed ID: 32540096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of transfusion effect of different platelet matching schemes in patients with platelet transfusion refractoriness].
    Liang YJ; Wang H; Zhao PZ; Wang F; Li Q; Xu Y; Wu YX; Zhang DM; He XH
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(11):865-869. PubMed ID: 38462363
    [No Abstract]   [Full Text] [Related]  

  • 13. Rebound and overshoot of donor-specific antibodies to human leukocyte antigens (HLA) during desensitization with plasma exchanges in hematopoietic progenitor cell transplantation: A case report.
    Hassan S; West KA; Ward WW; Kanakry JA; Flegel WA
    Transfusion; 2021 Jun; 61(6):1980-1986. PubMed ID: 33899963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantation.
    Lapierre V; Aupérin A; Tayebi H; Chabod J; Saas P; Michalet M; François S; Garban F; Giraud C; Tramalloni D; Oubouzar N; Blaise D; Kuentz M; Robinet E; Tiberghien P;
    Blood; 2002 Aug; 100(4):1484-9. PubMed ID: 12149235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
    Nickel RS; Horan JT; Abraham A; Qayed M; Haight A; Ngwube A; Liang H; Luban NLC; Hendrickson JE
    Br J Haematol; 2020 Apr; 189(1):162-170. PubMed ID: 31674662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type.
    Subramanian S; Cohn C; DeFor T; Welbig J; Brunstein C; El Jurdi N; Weisdorf D
    Transfusion; 2021 Jul; 61(7):2064-2074. PubMed ID: 33899243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation.
    Hassan S; Regan F; Brown C; Harmer A; Anderson N; Beckwith H; Roufosse CA; Santos-Nunez E; Brookes P; Taube D; Willicombe M
    Am J Transplant; 2019 Jun; 19(6):1720-1729. PubMed ID: 30582278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-CD36 Mediated Platelet Transfusion Refractoriness and Related Cases After Stem Cell Transplantation].
    Zhou Y; Li LL; Zhong ZL; Liu XJ; Liu JL; Shen WD; Wu GG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):541-546. PubMed ID: 29665929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage Transplantation with Cord Blood for Graft Rejection of Peripheral Blood Stem Cells due to Donor Specific Antibody.
    de Leon MRP; Takahashi S; Onozawa M; Ito M; Nakano M; Senjo H; Chiba M; Ohigashi H; Yokoyama E; Sugita J; Hashimoto D; Teshima T
    Blood Cell Ther; 2020 Nov; 3(4):74-77. PubMed ID: 36711008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation].
    Chen Y; Xu LP; Liu DH; Chen YH; Han W; Shi HX; Zhang XH; Wang JZ; Chen H; Liu KY; Huang XJ; Lu DP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):964-6. PubMed ID: 17650420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.